Ryan Spencer - 18 Jun 2025 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Director
Signature
/s/ Shane Ward, Attorney-in-Fact
Issuer symbol
CDTX
Transactions as of
18 Jun 2025
Transactions value $
$0
Form type
4
Filing time
18 Jun 2025, 17:05:35 UTC
Previous filing
20 Feb 2025
Next filing
29 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Spencer Ryan Director C/O CIDARA THERAPEUTICS, INC., 6310 NANCY RIDGE DRIVE SUITE 101, SAN DIEGO /s/ Shane Ward, Attorney-in-Fact 18 Jun 2025 0001777938

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Stock Option (right to buy) Award $0 +11,100 $0 11,100 18 Jun 2025 Common Stock 11,100 $21.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest on the earlier of (i) June 18, 2026 or (ii) the day prior to the date of the Issuer's 2026 annual meeting of stockholders.